Groesbeck Investment Management Corp Abbott Laboratories Transaction History

Groesbeck Investment Management Corp

$72.2 Million
Q2 2024

A detailed history of Groesbeck Investment Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Groesbeck Investment Management Corp holds 8,279 shares of ABT stock, worth $932,546. This represents 1.19% of its overall portfolio holdings.

Number of Shares

8,279

Previous 8,400 1.44%

Holding current value

$932,546

Previous $955,000 9.95%

% of portfolio

1.19%

Previous 1.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$100.73 - $112.44 $12,188 - $13,605	-121 Reduced 1.44%	8,279 $860,000
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $51,035 - $61,685	-500 Reduced 5.62%	8,400 $913,000
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $611,375 - $745,532	-5,362 Reduced 37.6%	8,900 $1.05 Million
Q3 2021 Oct 27, 2021	SELL	$116.66 - $129.06 $228,186 - $252,441	-1,956 Reduced 12.06%	14,262 $1.69 Million
Q2 2021 Jul 30, 2021	BUY	$105.79 - $124.53 $185,238 - $218,052	1,751 Added 12.1%	16,218 $1.88 Million
Q1 2021 May 05, 2021	SELL	$108.84 - $128.23 $75,970 - $89,504	-698 Reduced 4.6%	14,467 $1.73 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $101,220 - $110,300	-964 Reduced 5.98%	15,165 $1.66 Million
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $100,804 - $122,419	-1,100 Reduced 6.38%	16,129 $1.76 Million
Q2 2020 Jul 06, 2020	SELL	$76.57 - $98.0 $30,398 - $38,906	-397 Reduced 2.25%	17,229 $1.58 Million
Q1 2020 Jun 02, 2020	SELL	$62.82 - $91.86 $18,594 - $27,190	-296 Reduced 1.65%	17,626 $1.39 Million
Q4 2019 Jan 22, 2020	SELL	$78.51 - $87.4 $265,756 - $295,849	-3,385 Reduced 15.89%	17,922 $1.56 Million
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $19,314 - $20,942	-236 Reduced 1.1%	21,307 $1.78 Million
Q2 2019 Jul 26, 2019	SELL	$72.88 - $85.0 $142,553 - $166,260	-1,956 Reduced 8.32%	21,543 $1.81 Million
Q1 2019 May 03, 2019	SELL	$66.22 - $80.06 $105,422 - $127,455	-1,592 Reduced 6.34%	23,499 $1.88 Million
Q4 2018 Jan 25, 2019	SELL	$65.56 - $74.27 $127,317 - $144,232	-1,942 Reduced 7.18%	25,091 $1.82 Million
Q3 2018 Oct 18, 2018	SELL	$60.81 - $73.36 $105,991 - $127,866	-1,743 Reduced 6.06%	27,033 $1.98 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $74,035 - $81,712	-1,286 Reduced 4.28%	28,776 $1.76 Million
Q1 2018 May 02, 2018	SELL	$56.27 - $63.62 $17,950 - $20,294	-319 Reduced 1.05%	30,062 $1.8 Million
Q4 2017 Feb 07, 2018	SELL	$53.68 - $57.47 $48,204 - $51,608	-898 Reduced 2.87%	30,381 $1.73 Million
Q3 2017 Oct 16, 2017	BUY	$48.06 - $53.64 $1.5 Million - $1.68 Million	31,279	31,279 $1.67 Million

Others Institutions Holding ABT

# of Institutions

3,137

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Groesbeck Investment Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Groesbeck Investment Management Corp with notifications on news.

Account

Groesbeck Investment Management Corp Abbott Laboratories Transaction History